BCAT2 modulator (Icagen)

N/A

Report date: 2025/03/18 18:07:09
NME

Base Information

Drug NameBCAT2 modulator (Icagen)
Drug Alias Namebranched chain amino acid transaminase 2 modulator (Icagen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBranched-chain-amino-acid aminotransferase, mitochondrial modulators
TargetsBranched-chain-amino-acid aminotransferase, mitochondrial
Therapy Area/IndicationsOrganic acidemiaDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesIcagen Inc
Inactive CompaniesN/A
Active IndicationsOrganic acidemiaDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A